BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15796964)

  • 1. Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma.
    Cavazzini F; De Wolf-Peeters C; Wlodarska I
    Cancer Genet Cytogenet; 2005 Apr; 158(2):167-71. PubMed ID: 15796964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease.
    Jundt F; Kley K; Anagnostopoulos I; Schulze Pröbsting K; Greiner A; Mathas S; Scheidereit C; Wirth T; Stein H; Dörken B
    Blood; 2002 Apr; 99(8):3060-2. PubMed ID: 11929801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
    Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
    Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription.
    Stein H; Marafioti T; Foss HD; Laumen H; Hummel M; Anagnostopoulos I; Wirth T; Demel G; Falini B
    Blood; 2001 Jan; 97(2):496-501. PubMed ID: 11154228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.
    Torlakovic E; Tierens A; Dang HD; Delabie J
    Am J Pathol; 2001 Nov; 159(5):1807-14. PubMed ID: 11696441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma.
    Steimle-Grauer SA; Tinguely M; Seada L; Fellbaum C; Hansmann ML
    Virchows Arch; 2003 Mar; 442(3):284-93. PubMed ID: 12647220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition.
    Renné C; Martín-Subero JI; Hansmann ML; Siebert R
    J Mol Diagn; 2005 Aug; 7(3):352-6. PubMed ID: 16049307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas.
    Atayar C; Poppema S; Blokzijl T; Harms G; Boot M; van den Berg A
    Am J Pathol; 2005 Jan; 166(1):127-34. PubMed ID: 15632006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
    Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
    Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
    Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
    Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oct2 and Bob1 are sensitive and specific markers in lineage determination of B cell lymphomas with no expression of conventional B cell markers.
    Yin L; Xu J; Li M; Reddy V; Zhou Q; Liu H; Chu P; Zhang Q; Huang Q; Gao Z; Liang X; Wang HY; Pan Z
    Histopathology; 2016 Nov; 69(5):775-783. PubMed ID: 27319306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large B-cell lymphoma with Hodgkin's features.
    García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
    Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
    Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma?
    Martín-Subero JI; Knippschild U; Harder L; Barth TF; Riemke J; Grohmann S; Gesk S; Höppner J; Möller P; Parwaresch RM; Siebert R
    Leukemia; 2003 Nov; 17(11):2214-9. PubMed ID: 14523479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2.
    Nagel S; Schneider B; Rosenwald A; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
    Genes Chromosomes Cancer; 2011 Dec; 50(12):996-1009. PubMed ID: 21987443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.
    Hertel CB; Zhou XG; Hamilton-Dutoit SJ; Junker S
    Oncogene; 2002 Jul; 21(32):4908-20. PubMed ID: 12118370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.